Novartis, a Swiss pharmaceutical giant, has just opened a new manufacturing plant in Carlsbad, California. This facility is part of a bigger plan to invest $23 billion in the United States over the next five years. The focus of this new plant is on making cancer drugs, specifically for a treatment c
In the world of heart health, a new player has emerged. This player is called zalunfiban. It's a special kind of medicine. It's designed to help people who are having a certain type of heart attack. This type is known as ST-segment elevation myocardial infarction, or STEMI for short. Zalunfiban is
Yeasts are tiny powerhouses. They've been helping humans make bread, beer, and wine for ages. Now, scientists are using them to make medicines too. One such yeast, Kluyveromyces lactis, is known for its work in the dairy industry. But now, it's being used in a new way. Scientists have developed a me
Texas has taken a bold step by suing Tylenol's maker, Kenvue, and its former owner, Johnson & Johnson. The lawsuit claims these companies misled the public about Tylenol's safety during pregnancy. The main concern? A possible link between Tylenol and developmental issues like autism and ADHD. The l
The 15th European Immunogenicity Platform Open Symposium took place in Lisbon from February 22-24, 2024. This event brought together professionals from various fields, including industry, regulatory bodies, and academia. They gathered to discuss the challenges posed by the immune response to bioph
In Scotland, researchers took a close look at how chiral drugs make their way into rivers. They spent a year studying five community septic tanks. The goal was to figure out how these tanks affect the amounts and types of chiral drugs that end up in nearby rivers. The study focused on 25 different c
Making drugs that are packed into tiny lipid bubbles, called liposomes, is a big deal in medicine. Usually, this process needs a lot of heat, which costs a lot of energy and time. Plus, it can mess up the drugs and the bubbles. But, what if there's a way to do it without all that heat? Scie
In recent years, the biopharmaceutical industry has seen a significant shift. Chinese companies are now at the forefront of developing innovative drugs. This trend has caught the attention of U. S. pharmaceutical giants, who are increasingly looking to China for promising new treatments. One notabl
Baden-Wuerttemberg, a region in Germany, is exploring ways to grow medicinal plants. This is not just about picking plants that can easily grow there, but also about looking at the bigger picture. They are using a tool called SWOT analysis. It stands for Strengths, Weaknesses, Opportunities, and Th
Creating stable formulations for biopharmaceuticals like infliximab is no easy task. Scientists explored using 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to keep infliximab from degrading. They made both liquid and solid formulations. For the solid version, they used a scaled-up high-speed electrospin
